Patents by Inventor Sunil Nadkarni

Sunil Nadkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 2-Propene-1-Ones As Hsp 70 Inducers
    Publication number: 20080207608
    Abstract: The present invention relates to novel compounds of 2-propene-1-one series, of general formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them, wherein R5, R6, Q and Y are as defined in the specification. The present invention also relates to a process for preparing such compounds, compositions containing such compounds, and use of such compound and composition in medicine.
    Type: Application
    Filed: April 11, 2005
    Publication date: August 28, 2008
    Inventors: Prabhat Kumar, Uttam Mane, Ramesh Gupta, Sunil Nadkarni, Anookh Mohanan, Ruchi Tandon, Siralee Munshi
  • Nebivolol and Its Pharmaceutically Acceptable Salts, Process for Preparation and Pharmaceutical Compositions of Nebivolol
    Publication number: 20070259950
    Abstract: The present invention provides an improved process for the synthesis of nebivolol or its pharmaceutically acceptable salts, more particularly hydrochloride salt of formula (I). The present invention further provides a new Form T1 of nebivolol and its pharmaceutically acceptable salts. The present invention also provides pharmaceutical compositions and process for the preparation of a solid oral dosage form of nebivolol hydrochloride of formula (I), without the use of wetting agent, and optionally using binder and/or disintegrant.
    Type: Application
    Filed: August 1, 2005
    Publication date: November 8, 2007
    Applicant: Torrent Pharmaceuticals Limited
    Inventors: Rakesh Sheth, Srinivasarao Attanti, Hasmukh Patel, Vinodkumar Gupta, Sunil Nadkarni
  • Process for preparation of polymorphic form of sertraline hydrochloride
    Publication number: 20060167113
    Abstract: The invention discloses a process for preparation of sertraline salts particularly sertraline hydrochloride Form V by dissolving or suspending sertraline mandelate in a solvent, reducing the pH of the solution or the suspension and isolating salt of sertraline The invention also provides for a pharmaceutical composition comprising said sertraline salt as active ingredient
    Type: Application
    Filed: November 3, 2003
    Publication date: July 27, 2006
    Applicant: Torrent Pharmaceuticals Ltd.
    Inventor: Sunil Nadkarni
  • Novel dosage form
    Publication number: 20060153916
    Abstract: A dosage form comprising of a high dose, high solubility active ingredient as modified release and a low dose active ingredient as immediate release where the weight ratio of immediate release active ingredient and modified release active ingredient is from 1:10 to 1:15000 and the weight of modified release active ingredient per unit is from 500 mg to 1500 mg; a process for preparing the dosage form.
    Type: Application
    Filed: August 1, 2003
    Publication date: July 13, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Qupta
  • Novel drug delivery system
    Publication number: 20060018934
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 26, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Gupta
  • Novel drug delivery system
    Publication number: 20060018933
    Abstract: A novel modified release dosage form comprising of a high solubility active ingredient, which utilizes dual retard technique to effectively reduce the quantity of release controlling agents. Present invention can optionally comprise additionally another active ingredient as an immediate release form or modified release form. Present invention also relates to a process for preparing the said formulation.
    Type: Application
    Filed: May 19, 2005
    Publication date: January 26, 2006
    Inventors: Navin Vaya, Rajesh Karan, Sunil Nadkarni, Vinod Gupta